Reciprocal influence of salt intake on adrenal glomerulosa and renal vascular responses to angiotensin II in normal man

N K Hollenberg, W R Chenitz, D F Adams, G H Williams, N K Hollenberg, W R Chenitz, D F Adams, G H Williams

Abstract

The adrenal glomerulosa cell and the renal vasculature respond to similar arterial angiotensin II (A II) levels. We have assessed the effect of decreased sodium intake on their responses to A II in man. Studies were performed in 42 normal subjects in balance on a daily intake of 100 meq potassium and either 200 or 10 meq sodium/day. Renal blood flow was measured with (133)Xe and arterial A II, renin and aldosterone concentrations by radioimmunoassay. A II was infused intravenously (1, 3, or 10 ng/kg/min) for 40-60 min; 14 subjects received graded doses. The A II level increased linearly with dose and plateaued within 3 min; blood pressure and renal vascular resistance showed a similar time-course. Aldosterone rose within 10 and plateaued within 20 min. Dose-response relationships were established between the rate of A II infusion and the adrenal, the renal vascular, and pressor responses. Sodium restriction reduced the pressor (P < 0.01) and the renal vascular response (P < 0.01), but potentiated the adrenal response to A II (P < 0.01). An excellent correlation was found between the plasma A II and aldosterone levels, but the slope of their regression relationship on a high (y = 0.13x + 6) and low salt intake (y = 0.32x + 14) differed significantly (P < 0.0005). Thus, sodium intake reciprocally influences vascular and adrenal responses to A II: salt restriction blunts the vascular response and potentiates the adrenal's, a physiologically important influence in view of aldosterone's role in sodium conservation.

References

    1. Proc Soc Exp Biol Med. 1965 Oct;120(1):26-9
    1. Anal Biochem. 1966 Jun;15(3):386-408
    1. J Clin Endocrinol Metab. 1967 Apr;27(4):568-75
    1. Endocrinology. 1967 Apr;80(4):703-6
    1. Proc Soc Exp Biol Med. 1967 Apr;124(4):1230-1
    1. Ann N Y Acad Sci. 1966 Nov 22;139(2):276-84
    1. Ann N Y Acad Sci. 1966 Nov 22;139(2):312-27
    1. Experientia. 1967 Jul 15;23(7):553-5
    1. J Clin Invest. 1967 Dec;46(12):2101-8
    1. Endocrinology. 1968 Nov;83(5):1108-16
    1. J Clin Endocrinol Metab. 1969 Feb;29(2):200-6
    1. Circ Res. 1969 May;24(5 Suppl):131-48
    1. Nephron. 1969;6(3):247-59
    1. J Clin Endocrinol Metab. 1969 Dec;29(12):1639-43
    1. Proc Natl Acad Sci U S A. 1969 Jul;63(3):718-23
    1. J Clin Invest. 1972 Jan;51(1):58-67
    1. Clin Sci. 1972 Jan;42(1):91-104
    1. J Lab Clin Med. 1972 May;79(5):848-62
    1. Clin Sci. 1972 Apr;42(4):489-504
    1. Clin Sci. 1972 Aug;43(2):209-18
    1. Lancet. 1972 Nov 25;2(7787):1106-7
    1. Circ Res. 1972 Nov;31(5):728-39
    1. Circ Res. 1972 Nov;31(5):750-7
    1. Circ Res. 1972 Nov;31(5):758-66
    1. J Lab Clin Med. 1973 Apr;81(4):632-40
    1. Circ Res. 1973 Jun;32(6):692-8
    1. N Engl J Med. 1973 Oct 4;289(14):745-7
    1. Am J Physiol. 1974 Jan;226(1):185-90
    1. J Clin Invest. 1964 Apr;43:659-69
    1. JAMA. 1960 Sep 17;174:234-40
    1. Pharmacol Rev. 1965 Jun;17:143-82
    1. J Clin Invest. 1965 Jul;44:1171-86

Source: PubMed

3
Subscribe